Profile data is unavailable for this security.
About the company
Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.
- Revenue in EUR (TTM)23.31m
- Net income in EUR-21.99m
- Incorporated2002
- Employees211.00
- LocationMedian Technologies SALes Deux Arcs - Batiment B 1800Route des CretesVALBONNE 06560FranceFRA
- Phone+33 493333777
- Fax+33 492906599
- Websitehttps://mediantechnologies.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stille AB | 51.98m | 3.80m | 123.41m | 208.00 | 32.44 | 1.89 | 14.80 | 2.37 | 4.50 | 4.50 | 62.09 | 77.10 | 0.531 | 1.55 | 7.66 | 3,891,176.00 | 3.88 | 6.20 | 4.55 | 7.11 | 52.45 | 47.21 | 7.31 | 9.48 | 1.87 | -- | 0.00 | 16.29 | 93.27 | 29.47 | 118.44 | 20.53 | 13.88 | -- |
| EKF Diagnostics Holdings PLC | 57.72m | 7.03m | 123.61m | 297.00 | 18.44 | 1.56 | 9.79 | 2.14 | 0.0135 | 0.0135 | 0.1109 | 0.1597 | 0.6209 | 3.16 | 7.34 | 165,745.90 | 7.98 | 5.79 | 8.77 | 6.76 | 49.79 | 49.42 | 12.86 | 8.62 | 3.47 | -- | 0.0152 | -- | -4.59 | 2.25 | 165.39 | 11.16 | 3.02 | -- |
| Genovis AB | 10.97m | 1.99m | 127.09m | 36.00 | 63.41 | 5.13 | 41.92 | 11.58 | 0.3225 | 0.3225 | 1.78 | 3.99 | 0.3404 | -- | -- | 3,644,719.00 | 6.18 | 15.62 | 6.57 | 17.56 | 90.28 | 88.86 | 18.16 | 25.11 | -- | -- | 0.2171 | 0.00 | -17.62 | 16.58 | -46.48 | 28.08 | -1.42 | -- |
| Oncosem Onkolojik Sistemlr Sny v Tcrt AS | 11.25m | 286.55k | 135.47m | 358.00 | 472.78 | 19.19 | 98.22 | 12.04 | 0.624 | 0.624 | 24.49 | 15.37 | 1.26 | 4.61 | 4.26 | 2,000,638.00 | 3.20 | -7.80 | 4.30 | -10.68 | 36.39 | 33.56 | 2.55 | -8.41 | 1.86 | 3.04 | 0.1562 | -- | 7.85 | 50.94 | 48.65 | -- | 10.14 | -- |
| Nordhealth As | 50.24m | -10.65m | 138.36m | 450.00 | -- | 3.71 | -- | 2.75 | -1.54 | -1.54 | 7.25 | 9.41 | 0.6188 | -- | 8.10 | 1,394,815.00 | -13.11 | -- | -14.99 | -- | 82.95 | -- | -21.19 | -- | -- | -- | 0.00 | -- | 24.03 | -- | 31.06 | -- | -- | -- |
| Carasent AB (publ) | 30.94m | -1.75m | 162.61m | 196.00 | -- | 2.03 | 39.11 | 5.26 | -0.268 | -0.268 | 4.64 | 11.78 | 0.3226 | -- | 7.35 | 1,652,936.00 | -1.82 | -- | -2.04 | -- | 84.59 | -- | -5.65 | -- | -- | -- | 0.0412 | -- | 12.27 | -- | 9.46 | -- | -- | -- |
| Nyxoah SA | 5.64m | -83.72m | 171.89m | 184.00 | -- | 2.94 | -- | 30.48 | -2.24 | -2.24 | 0.1509 | 1.36 | 0.0477 | 0.3543 | 2.15 | 30,646.74 | -70.84 | -27.03 | -83.81 | -29.81 | 64.36 | 63.56 | -1,484.66 | -1,347.97 | 1.41 | -- | 0.2934 | -- | 3.98 | -- | -37.08 | -- | 86.96 | -- |
| Detection Technology Oyj | 105.34m | 8.94m | 175.13m | 494.00 | 19.60 | 2.41 | 16.27 | 1.66 | 0.6097 | 0.6097 | 7.19 | 4.96 | 1.18 | 2.58 | 3.19 | 216,295.30 | 10.02 | 8.54 | 12.22 | 10.73 | 46.33 | 47.22 | 8.50 | 7.85 | 3.05 | 38.10 | 0.00 | 60.32 | 3.58 | 0.9636 | 101.97 | -2.29 | -11.31 | 5.64 |
| Guerbet SA | 809.67m | 7.74m | 175.96m | 2.91k | 34.25 | 0.4664 | 2.50 | 0.2173 | 0.4064 | 0.4064 | 64.25 | 29.85 | 0.7865 | 0.546 | 4.90 | 278,715.70 | 0.4619 | 0.92 | 0.6055 | 1.20 | 78.03 | 76.51 | 0.5873 | 1.19 | 1.03 | 1.46 | 0.5172 | 64.79 | 7.05 | 0.5853 | -32.61 | -15.50 | -0.8569 | -- |
| Prim SA | 240.47m | 14.55m | 218.92m | 954.00 | 14.00 | 1.65 | 8.58 | 0.9104 | 0.9176 | 0.9176 | 14.13 | 7.80 | 1.17 | 1.97 | 4.17 | 251,008.80 | 7.09 | 6.27 | 10.40 | 8.50 | 38.77 | 37.70 | 6.05 | 5.85 | 1.20 | 144.87 | 0.1399 | 63.10 | 7.68 | 9.08 | -13.83 | -0.5366 | 13.50 | 6.35 |
| Affluent Medical SAS | 4.12m | -14.74m | 219.20m | 76.00 | -- | 6.90 | -- | 53.23 | -0.3759 | -0.3759 | 0.1051 | 0.5365 | 0.0709 | -- | 0.9541 | 59,681.16 | -25.40 | -23.76 | -32.61 | -27.59 | 1.34 | -226.93 | -358.01 | -1,815.40 | -- | -924.30 | 0.5030 | -- | -- | -- | 5.84 | -- | -- | -- |
| Median Technologies SA | 23.31m | -21.99m | 230.22m | 211.00 | -- | -- | -- | 9.88 | -1.16 | -1.16 | 1.23 | -2.08 | 0.8894 | -12.98 | 3.92 | 96,717.84 | -83.91 | -60.70 | -- | -232.35 | 102.73 | 102.32 | -94.35 | -97.73 | 0.3543 | -26.56 | -- | -- | 3.25 | 20.72 | -9.83 | -- | 43.77 | -- |
| Onward Medical NV | 1.11m | -38.65m | 234.40m | 102.00 | -- | 6.74 | -- | 210.79 | -0.866 | -0.866 | 0.0249 | 0.6209 | 0.0215 | -- | 9.11 | 10,901.96 | -74.86 | -55.03 | -92.84 | -61.19 | 77.16 | -- | -3,475.81 | -39,652.37 | 4.30 | -17.13 | 0.352 | -- | 236.76 | -- | 1.26 | -- | 3.88 | -- |
| Tristel Plc | 53.40m | 7.63m | 234.82m | 265.00 | 30.88 | 6.18 | 21.64 | 4.40 | 0.1383 | 0.1383 | 0.9676 | 0.6915 | 1.04 | 1.93 | 5.81 | 175,328.30 | 14.85 | 9.60 | 17.57 | 11.09 | 80.62 | 80.90 | 14.29 | 11.04 | 2.96 | -- | 0.1512 | 120.71 | 10.80 | 7.96 | 2.33 | 5.42 | -3.59 | 18.10 |
| Stratec SE | 256.91m | 15.65m | 250.82m | 1.42k | 16.15 | 1.05 | 7.28 | 0.9763 | 1.29 | 1.29 | 21.13 | 19.75 | 0.5825 | 1.32 | 5.65 | 177,177.20 | 3.55 | 6.72 | 4.24 | 7.96 | 29.09 | 28.41 | 6.09 | 9.63 | 1.65 | 6.85 | 0.3552 | 37.35 | -4.73 | 3.76 | 4.24 | 2.35 | -7.49 | -6.51 |
Data as of Feb 10 2026. Currency figures normalised to Median Technologies SA's reporting currency: Euro EUR
7.63%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Herald Investment Management Ltd.as of 31 Dec 2024 | 519.99k | 1.42% |
| Aguja Capital GmbHas of 31 Oct 2025 | 500.00k | 1.36% |
| Apo Asset Management GmbHas of 30 Apr 2024 | 477.24k | 1.30% |
| OFI Invest Asset Management SAas of 29 Jan 2026 | 450.00k | 1.23% |
| Montpensier Arbevel SASas of 30 Jun 2025 | 312.74k | 0.85% |
| Groupama Asset Management SAas of 31 Jan 2025 | 168.84k | 0.46% |
| Alphajet Fair Investors SASas of 03 Feb 2026 | 115.00k | 0.31% |
| HSBC Global Asset Management (France) SAas of 31 Dec 2025 | 108.30k | 0.30% |
| Pure Capital SAas of 30 Jun 2025 | 97.16k | 0.27% |
| PEH Wertpapier AG (Germany)as of 30 Jun 2025 | 52.50k | 0.14% |
More ▼
Data from 30 Jun 2025 - 03 Feb 2026Source: FactSet Research Systems Inc.
